| Product Name: | Vildagliptin Tablet |
| Brand Name: | Generics |
| Strength: | 50mg |
| Dosage Form: | Tablets (Uncoated) |
| Route of Administration: | Via oral Route |
| Packing: | 30s, 90, 100s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
| Therapeutic use: | Antidiabetic, Diabetology |
| Indication: | Vildagliptin is a DPP-4 inhibitor approved for the treatment of type 2 diabetes. Glucagon-like peptide-1 (GLP-1) is a hormone that is rapidly released from the intestine after eating. GLP-1 signals to the pancreas to increase insulin release, and reduce glucagon release, after a meal. |
| Storage: | Protect from moisture at a temperature not exceeding 30˚C. Do not freeze. Keep the container tightly closed in order to protect it from moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
Vildagliptin Tablet 50mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Vildagliptin Tablet 50mg
Each uncoated tablet contains:
Vildagliptin………… 50mg
Excipients……………Q.s.
THERAPEUTIC INDICATIONS:
Vildagliptin is a DPP-4 inhibitor approved for the treatment of type 2 diabetes. Glucagon-like peptide-1 (GLP-1) is a hormone that is rapidly released from the intestine after eating. GLP-1 signals to the pancreas to increase insulin release, and reduce glucagon release, after a meal.
CAUTION & WARNING:
CAUTION:
Read the enclosed leaflet before use.
Keep the medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH.
WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
Storage:
Protect form moisture at a temperature not exceeding 30˚C. Do not freeze.
Keep the container tightly closed in order to protect it from moisture.
Dosage: As directed by the Physician.